semaglutide brand name canada Health approves 1st generic version of Ozempic in the country Hims & Hers to bring
Description
From semaglutide and GLP-1 therapies to convenient delivery services, the possibilities are designed to empower you on your healthcare journey
Foundayo (orforglipron, FDA-approved April 2026) is Eli Lillys non-peptide small-molecule oral GLP-1
[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Mroz P
The test generates over 150 clinical insights that guide personalized treatment selection, ensuring that semaglutide or alternative therapies align with your unique metabolic biology
